AA-03-QM41_0.1uM Gene Set
| Dataset |
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
|
| Category |
transcriptomics
|
| Type |
drug perturbation |
| Description |
Dose=0.1uM, Angiogenesis Inhibitors;Inhibitors of Signal Transduction Pathways;IGF-1R Inhibitors targeting IGF1R (Novartis)
|
| Similar Terms |
|
| Downloads & Tools |
|
Genes
11 genes differentially expressed following the AA-03-QM41_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
increased expression
| Symbol |
Name |
Standardized Value |
|
BUD31
|
BUD31 homolog (S. cerevisiae)
|
1.67437
|
|
MYL6
|
myosin, light chain 6, alkali, smooth muscle and non-muscle
|
0.546436
|
|
RPL37A
|
ribosomal protein L37a
|
0.535106
|
|
FAU
|
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed
|
0.286202
|
|
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow
|
0.240483
|
|
TUBB
|
tubulin, beta class I
|
0.230511
|
decreased expression
| Symbol |
Name |
Standardized Value |
|
SSH1
|
slingshot protein phosphatase 1
|
-0.357614
|
|
ZNF740
|
zinc finger protein 740
|
-0.357614
|
|
XTBD1
|
XRN2 binding domain containing 1
|
-0.240483
|
|
CHD8
|
chromodomain helicase DNA binding protein 8
|
-0.21681
|
|
NOL11
|
nucleolar protein 11
|
-0.201691
|